Review article: dose optimisation of infliximab for acute severe ulcerative colitis-Reference-Cited by-同舟云学术

Review article: dose optimisation of infliximab for acute severe ulcerative colitis

Published:2017-01-11 Issue:5 Volume:45 Page:617-630
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Hindryckx P.¹²,Novak G.¹³,Vande Casteele N.¹,Laukens D.²,Parker C.¹,Shackelton L. M¹,Narula N.⁴,Khanna R.¹⁵,Dulai P.⁶,Levesque B. G¹⁶,Sandborn W. J¹⁶,D'Haens G.¹⁷,Feagan B. G.¹⁵⁸,Jairath V.¹⁵⁸

Affiliation:

1. Robarts Clinical Trials Inc.; University of Western Ontario; London Ontario Canada

2. Department of Gastroenterology; University of Ghent; Ghent Belgium

3. Department of Gastroenterology; Ljubljana University Medical Centre; Ljubljana Slovenia

4. Department of Medicine and Farncombe Family Digestive Health Research Institute; Division of Gastroenterology; McMaster University; Hamilton Ontario Canada

5. Department of Medicine; University of Western Ontario; London Ontario Canada

6. Division of Gastroenterology; University of California San Diego; La Jolla California USA

7. Inflammatory Bowel Disease Centre; Academic Medical Centre; Amsterdam The Netherlands

8. Department of Epidemiology and Biostatistics; University of Western Ontario; London Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13913/fullpdf

Reference75 articles.

1. Immunopathogenesis of IBD: Current state of the art;Souza;Nat Rev Gastroenterol Hepatol,2016

2. An overview of the natural history of inflammatory bowel diseases;Domenech;Dig Dis,2014

3. Cortisone in ulcerative colitis; final report on a therapeutic trial;Truelove;Br Med J,1955

4. European evidence-based Consensus on the management of ulcerative colitis: current management;Travis;J Crohns Colitis,2008

5. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial;Laharie;Lancet,2012

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

2. Evaluation of infliximab-induced genotoxicity and possible action on BCL-2 and P53 genes;Journal of Toxicology and Environmental Health, Part A;2024-06-26

3. PANTS extension study: how best to use anti-TNF drugs in Crohn's disease;The Lancet Gastroenterology & Hepatology;2024-06

4. Current Management of Acute Severe Ulcerative Colitis: New Insights on the Surgical Approaches;Journal of Personalized Medicine;2024-05-28

5. Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study;Intestinal Research;2024-05-07